Lunsumio Interactions
There are 244 drugs known to interact with Lunsumio (mosunetuzumab). Of the total drug interactions, 34 are major, 195 are moderate, and 15 are minor.
- View all 244 medications that may interact with Lunsumio
Most frequently checked interactions
View interaction reports for Lunsumio (mosunetuzumab) and the medicines listed below.
- acyclovir
- albuterol
- allopurinol
- amiodarone
- Anoro Ellipta (umeclidinium / vilanterol)
- atropine / diphenoxylate
- azelastine nasal
- Bactrim (sulfamethoxazole / trimethoprim)
- ciprofloxacin
- clindamycin
- colesevelam
- Eliquis (apixaban)
- Flonase (fluticasone nasal)
- Klor-Con M20 (potassium chloride)
- Lasix (furosemide)
- Metoprolol Succinate ER (metoprolol)
- montelukast
- Mucinex Maximum Strength (guaifenesin)
- multivitamin
- naproxen
- pantoprazole
- silodosin
- sodium chloride
- tadalafil
- Tazverik (tazemetostat)
- Tezspire (tezepelumab)
- tobramycin
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Uro-Mag (magnesium oxide)
More about Lunsumio (mosunetuzumab)
- Lunsumio consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Columvi
Columvi is used to treat certain types of diffuse large B-cell lymphoma (DLBCL) or large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.